BSE Healthcare Medical - Care Facilities FORTIS.BO

Fortis Healthcare Limited

$ 962.95 0.43 %

Fortis Healthcare Limited functions as a comprehensive provider of integrated medical services. The company delivers a full spectrum of healthcare, encompassing secondary, tertiary, and quaternary care, across India, the United Arab Emirates, Nepal, Sri Lanka, and various other international locations. Its operational framework includes hospitals, advanced diagnostic centers, and specialized day care facilities. Fortis is distinguished by its extensive array of medical and surgical specialties. These include, but are not limited to, cardiac sciences, cosmetology, dental sciences, dermatology, diabetology/endocrinology, emergency and trauma care, ear, nose, and throat (ENT), foetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatments, internal medicine, mental health and behavioral sciences, nephrology, neurosurgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplantation, rheumatology, thoracic surgery, transplantation medicine, urology, and various other essential support services. Established in 1995, the company's headquarters are situated in Gurugram, India.

CEO: Ashutosh Raghuvanshi - https://www.fortishealthcare.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 252.72

Loading data...

FORTIS.BO vs S&P500

Loading data...

No data available.

Quick ratio

0.80

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

69.93

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

13.77

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

11.14 %

reflects reasonable profitability, showing good use of equity.

ROIC

11.51 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

7.28

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.35

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.06

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

7.44 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
8.41 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.26 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.22 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.